HRCM
SAGE

Hood River Capital Management’s Sage Therapeutics SAGE Stock Holding History

Hood River Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-366,068
Closed -$51.4M – 116
2019
Q3 		$51.4M Buy
366,068
+2,636
+0.7% +$441K 2.63% 4
2019
Q2 		$66.5M Buy
363,432
+13,064
+4% +$2.23M 3.12% 1
2019
Q1 		$55.7M Buy
350,368
+208,942
+148% +$30.3M 2.8% 3
2018
Q4 		$13.5M Buy
141,426
+1,780
+1% +$204K 0.8% 58
2018
Q3 		$19.7M Buy
139,646
+19,238
+16% +$2.97M 0.87% 50
2018
Q2 		$18.8M Buy
120,408
+27,825
+30% +$4.37M 0.97% 49
2018
Q1 		$14.9M Buy
+92,583
New +$15.7M 0.84% 51

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Hood River Capital Management's SAGE Position: Q4 2019 in Review

Hood River Capital Management sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 366,068 shares — an estimated $51.4M sold.

Hood River Capital Management first reported a position in SAGE in Q1 2018 and held it in 7 quarters. The position peaked at $66.5M in Q2 2019. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • Hood River Capital Management reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Hood River Capital Management sold 366,068 Sage Therapeutics shares in Q4 2019, an estimated $51.4M.
  • Hood River Capital Management first reported a position in Sage Therapeutics in Q1 2018 and held it in 7 quarters.
  • Hood River Capital Management's Sage Therapeutics position peaked at $66.5M in Q2 2019.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on Hood River Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.